F-1/A: rYojbaba Co. Ltd. Files for IPO to Boost Consulting and Health Services
Registration Statement
rYojbaba Co., Ltd., a Japanese corporation specializing in labor consulting and osteopathic health services, has filed for an initial public offering (IPO) aiming to expand its operations and IT infrastructure.
Summary
- rYojbaba Co., Ltd. is seeking to raise capital through an IPO to enhance its consulting and health service offerings.
- The company plans to offer 1,250,000 common shares, with an underwriter option for an additional 187,500 shares, at an assumed IPO price of $4.00 per share.
- The IPO aims to fund working capital, develop an IT platform for labor consulting, hire additional consultants, expand consulting services abroad, and grow osteopathic clinics and beauty salons through M&A and franchising.
- rYojbaba operates two primary businesses in Japan: labor consulting and osteopathic health services.
- For the fiscal year ended December 31, 2024, rYojbaba generated revenues of $11,576,848 and net income of $1,332,399.
- The company intends to list its common shares on the NYSE American or the Nasdaq under the symbol RYOJ.
- Following the offering, Ryoji Baba, the CEO, will control approximately 71.3% of the voting power, making the company a controlled entity.
Sentiment
Score: 7
Explanation: The document presents a positive outlook with growth plans and solid financial results, but also acknowledges risks and challenges, resulting in a moderately positive sentiment.
Positives
- The IPO will provide capital for growth initiatives, including IT infrastructure and international expansion.
- rYojbaba has a proven track record with $11,576,848 in revenue and $1,332,399 in net income for FY24.
- The company's CEO, Ryoji Baba, has extensive experience in labor law, providing a competitive advantage.
- The company offers impartial consulting services, benefiting both employers and employees.
- The company has a high repeat customer rate of over 80% in its osteopathic clinics.
- The company has a long-standing business with a multifaceted approach to medical treatment.
Negatives
- The company will be a controlled entity post-IPO, potentially reducing corporate governance protections for minority shareholders.
- The company's success is heavily reliant on its senior management team, particularly CEO Ryoji Baba.
- The company operates in a competitive industry and may face challenges in maintaining its market position.
- The company's osteopathic clinic and beauty salon base is geographically concentrated in the Kyusyu area of Japan.
- The company may face restrictions on foreign investment related to Foreign Exchange and Foreign Trade Act in Japan.
Risks
- The company may need to raise additional capital in the future, potentially diluting current shareholders.
- The company may be classified as a Passive Foreign Investment Company (PFIC), leading to adverse tax consequences for U.S. holders.
- The company's inability to retain senior management could negatively impact its labor consulting business.
- The company's financial results could suffer if it cannot achieve adequate utilization and billing rates for its labor consultants.
- The company's business is vulnerable to changes in consumer preferences and economic conditions.
- The company may face strong competition from other providers in its service areas.
Future Outlook
The company intends to expand its consulting services to employers and employees, grow its customer base, expand its consulting business through IT platform implementation, strengthen its foundation to serve more customers by hiring additional consultants and administrative staff, and opportunistically pursue strategic acquisitions. The company also intends to expand stores nationwide, promote franchising and overseas expansion through business packaging, manage cost optimization through operations improvement, and selectively pursue acquisitions.
Management Comments
- Our primary mission is to improve and restore physical and mental health diminished by work related stress through our consulting and health services.
- We believe that work-induced stress is a serious and growing problem as profits over people dominate all sectors of contemporary business culture.
- We believe that the significant difference between our Company and our competitors is our ability to provide impartial services that are not tailored specifically to the employer or the employee.
Industry Context
The labor consulting industry is growing in Japan due to increasing awareness of labor rights and the complexity of labor laws. The osteopathic industry is also expanding, with a growing number of clinics and a focus on differentiated services.
Comparison to Industry Standards
- The company's osteopathic clinics have a repeat customer rate of over 80%, which is higher than the industry average.
- The company's consulting services have high unit price contracts, such as 300,000 yen per month, indicating a strong reputation and effectiveness.
- The company's osteopathic clinics have a higher number of insurance claims per clinic compared to the average in the Kyushu area.
- The company's osteopathic beauty salons have a higher number of reservations per month compared to the national average.
Related Party Transactions
- The company paid rent to Runbridge Inc., of which the CEO is a shareholder.
- The company recorded commission expenses from Global HR Technology, of which the CEO was a shareholder until January 1, 2024.
- The company has loans guaranteed by the CEO and a director of Sakai Seikotsuin Nishi Co., Ltd.
Stakeholder Impact
- Shareholders may experience dilution due to the issuance of new shares.
- Employees may benefit from the company's expansion and improved working environment.
- Customers may benefit from the company's enhanced services and wider availability.
- Suppliers may see increased business opportunities due to the company's growth.
Next Steps
- The company intends to apply to list its common shares on the NYSE American or the Nasdaq.
- The company will determine the actual offering price per common share based on market conditions at the time of pricing.
- The company will use the net proceeds from this offering to fund working capital and general corporate purposes.
Key Dates
| Date | Description |
|---|---|
| January 5, 2015 | Sakai Enterprise Co., Ltd. (now rYojbaba Co., Ltd.) was founded. |
| August 26, 2010 | Sakai Seikotsuin Nishi Co., Ltd. was founded. |
| October 1, 2019 | Sakai Enterprise Co., Ltd. was changed to Sakai Seikotsuin Co., Ltd. |
| October 22, 2021 | Sakai Seikotsuin Co., Ltd. was changed to rYojibaba Co., Ltd. |
| October 23, 2021 | Ryoji Baba and other shareholders acquired rYojibaba Co., Ltd. |
| January 2022 | rYojibaba Co., Ltd. acquired Sakai Seikotsuin Nishi Co., Ltd. |
| March 31, 2022 | rYojibaba Co., Ltd. was changed to rYojbaba Co., Ltd. |
| April 4, 2023 | rYojbaba Co., Ltd. entered into a Consulting and Services Agreement with HeartCore Enterprises, Inc. |
| September 7, 2023 | Warrant Exchange Agreement among HeartCore, rYojbaba Co., Ltd., and rYojbaba Holdings, Inc. |
| January 12, 2024 | rYojbaba Holdings, Inc. distributed common shares of rYojbaba Co., Ltd. in a spin-off transaction. |
| January 12, 2024 | Second Warrant Exchange Agreement among HeartCore, rYojbaba Co., Ltd., and rYojbaba Holdings, Inc. |
| March 3, 2024 | The Company approved a forward stock split of the Companys issued and outstanding common shares, at a ratio of 1-for-1,000. |
| March 3, 2024 | The Company allotted 300,000 stock acquisition rights to HeartCore. |
| May 8, 2025 | Date of the prospectus. |
Keywords
IPO, labor consulting, osteopathic clinics, health services, Japan, Ryojibaba, RYOJ, initial public offering, consulting, osteopathic
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.